Julie Gerberding, MD, MPH

Dr. Julie Louise Gerberding is the President and CEO of the Foundation for the National Institutes of Health (FNIH), a non-profit organization that builds public-private-patient biomedical research partnerships to address important medical challenges in support of the NIH mission. She also co-chairs the CSIS Bipartisan Alliance for Global Health Security. Dr. Gerberding formerly served as President of Merck Vaccines and as Executive Vice President and Chief Patient Officer at Merck & Co., Inc.  From 2003-2009, Dr. Gerberding led the U.S. Centers for Disease Control and Prevention (CDC).  Her current board service includes HilleVax, Mayo Clinic, National Health Council, and Case Western Reserve University.  Dr. Gerberding is a member of the National Academy of Medicine and the adjunct faculties of the University of California, San Francisco, and Case Western Reserve University.


Back to Board of Directors and Officers

Home